Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

Rationale: Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives: To prospectively characterize the clinical presentation, histopathology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Respir Crit Care Med
Autores principales: Zamanian, Roham T., Hedlin, Haley, Greuenwald, Paul, Wilson, David M., Segal, Joshua I., Jorden, Michelle, Kudelko, Kristina, Liu, Juliana, Hsi, Andrew, Rupp, Allyson, Sweatt, Andrew J., Tuder, Rubin, Berry, Gerald J., Rabinovitch, Marlene, Doyle, Ramona L., de Jesus Perez, Vinicio, Kawut, Steven M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855067/
https://ncbi.nlm.nih.gov/pubmed/28934596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201705-0943OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares